Biotech News - Allergan, Inc. (Public, NYSE:AGN)

Allergan, Inc. (Public, NYSE:AGN)

Allergan profit falls in 3Q, plans to buy French company
Los Angeles Business from bizjournals - November 1, 2006
Print this Article Email this Article Reprints RSS Feeds Most Viewed
Most Emailed
Allergan Inc.'s third quarter profit was down because of charges due
to its March buyout of Inamed, and it announced plans to buy Paris'
Groupe Corneal Laboratoires for $216 million, the company said
Wednesday.

Revenue was $806.8 million, up 32 percent from $611.4 million in the
year-ago period.

More:
http://www.bizjournals.com/losangeles/stories/2006/10/30/daily36.html

http://tech.groups.yahoo.com/group/biotech-news/
http://www.arizonabiotech.com/
http://www.azhttp.com/

http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/

Yahoo! Groups Links

<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/biotech-news/

<*> Your email settings:
Individual Email | Traditional

<*> To change settings online go to:
http://groups.yahoo.com/group/biotech-news/join
(Yahoo! ID required)

<*> To change settings via email:
mailto:biotech-news-digest@yahoogroups.com
mailto:biotech-news-fullfeatured@yahoogroups.com

<*> To unsubscribe from this group, send an email to:
biotech-news-unsubscribe@yahoogroups.com

<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/